Icotinib With Concurrent Radiotherapy Versus Chemotherapy With Concurrent Radiotherapy in Non-small Cell Lung Cancer

NCT02215356 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-small Cell Lung Cancer

Interventions

DRUG: Icotinib with concurrent radiotherapy
DRUG: Chemoradiotherapy

Sponsor

Betta Pharmaceuticals Co., Ltd.